News >

Expert Reflects on Rapidly Evolving Field of MCL

Caroline Seymour
Published: Thursday, Aug 15, 2019

Simon Rule, MD, PhD, a professor of hematology at Plymouth University Medical School

Simon Rule, MD, PhD

Frontline and second-line treatment for patients with mantle cell lymphoma (MCL) are fairly well established, but the emergence of novel agents and the potential for CAR T-cell therapy may lead to a new and perhaps chemotherapy-free paradigm, said Simon Rule, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication
x